Charles River Laboratories International, Inc. CRL

292.84 (1.60) (0.54%) as of 25 Sep
Market cap
$14.1B
P/E
0.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(7.69%) (6.01%) (4.35%) (2.48%)

+8 more TTM periods

ROA
(3.16%) (2.41%) (1.97%) (1.15%)
ROIC
1.07% 0.81% 0.31% 1.63%
Return on Tangible Assets
(12.62%) (9.69%) (7.28%) (4.45%)
Average Days of Receivables
64.96 63.47 64.44 66.63
Free Cash Flow per Share
7.72 7.99 10.46 11.05
Free Cash Flow
370.61 391.29 518.49 543.67
Capital Expenditures
(211.54) (215.74) (219.15) (205.82)
Piotroski F-Score
4.00 3.00 4.00 2.00
Other line items
Cash ROIC
10.29% 10.46% 13.36% 12.92%
Accounts Receivable Turnover
5.41 5.53 5.62 5.41
Accounts Payable Turnover
18.78 19.25 18.62 17.84
Inventory Turnover
8.60 8.39 9.32 8.54
Average Days of Payables
19.11 17.93 20.17 22.71
Days of Inventory on Hand
46.94 48.15 40.55 40.51
Tax Rate
0.29 0.11 0.43 2.59
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
19.06% 18.00% 18.51% 18.46%
Share Based Compensation of Revenue
2.08% 1.99% 1.77% 1.76%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
(2.44) (3.29) (5.11) (8.41)
Depreciation/Fixed assets
0.31 0.34 0.34 0.40
Capex/Depreciation
(0.46) (0.42) (0.39) (0.32)
Revenue per Share
83.28 82.27 81.01 81.76
Operating CF per Share
12.12 12.40 14.88 15.23
Capex per Share
(4.41) (4.41) (4.42) (4.18)
Capex to Sales
0.05 0.05 0.05 0.05
Net Profit Margin
(5.96%) (4.59%) (3.59%) (2.21%)

Fold the line items

Columns are period end dates